financetom
Business
financetom
/
Business
/
SpaceX warns investors Elon Musk could return to US politics, Bloomberg reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
SpaceX warns investors Elon Musk could return to US politics, Bloomberg reports
Jul 22, 2025 12:17 PM

(Reuters) -Elon Musk, who most recently served as a senior adviser to President Donald Trump, may return to U.S. politics, Bloomberg News reported on Tuesday, citing SpaceX documents and people familiar with the content.

The company added the language laying out such "risk factors" in paperwork sent to investors discussing a tender offer, according to Bloomberg.

It was the first time this language is believed to have appeared in these tender offers, Bloomberg reported, citing some of the sources.

SpaceX did not immediately respond to a Reuters request for comment on the report.

Billionaire Musk's SpaceX is planning an insider share sale that would value the space firm at about $400 billion, Bloomberg reported last week.

Musk on Sunday said in a post on X he was back to working seven days a week and sleeping in the office.

Musk, the world's richest man, spent nearly $300 million in 2024 to help Trump and other Republicans get elected. He lead the administration's sweeping cost-cutting campaign, upending several federal agencies but ultimately failed to deliver the massive savings he had sought.

A spat between Trump and Musk culminated in a public falling out on June 5. Musk announced the formation of a new U.S. political party in response to Trump signing his sweeping tax and spending bill into law in July.

(Reporting by Juby Babu in Mexico City; Editing by Anil D'Silva)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Dxp Enterprises Insider Sold Shares Worth $250,860, According to a Recent SEC Filing
Dxp Enterprises Insider Sold Shares Worth $250,860, According to a Recent SEC Filing
Aug 25, 2025
01:47 PM EDT, 08/25/2025 (MT Newswires) -- John Jay Jeffery, Senior Vice President, on August 22, 2025, sold 2,000 shares in Dxp Enterprises ( DXPE ) for $250,860. Following the Form 4 filing with the SEC, Jeffery has control over a total of 20,008 common shares of the company, with 20,008 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1020710/000102071025000148/xslF345X05/wk-form4_1756143693.xml Price: 124.51, Change:...
US appeals court orders SEC to review short-selling rules
US appeals court orders SEC to review short-selling rules
Aug 25, 2025
NEW YORK, Aug 25 (Reuters) - A U.S. appeals court on Monday ordered the U.S. Securities and Exchange Commission to assess the economic impact of President Joe Biden-era rules aimed at boosting transparency of short sell trades, in a partial victory for hedge funds that brought the case. The future of the rule is unclear. The review will now fall...
MannKind, Backed By Blackstone, Expands Cardiorenal Focus With $360 Million Deal
MannKind, Backed By Blackstone, Expands Cardiorenal Focus With $360 Million Deal
Aug 25, 2025
MannKind Corporation on Monday agreed to acquire scPharmaceuticals Inc. for a deal value of up to approximately $360 million, or $5.35 per share. The deal marks MannKind’s strategic expansion into cardiorenal medicine, establishing its cardiometabolic business alongside its orphan lung division. It is also made possible on the heels of MannKind’s $500 million strategic financing agreement with Blackstone. ScPharmaceuticals ( SCPH...
FDA Flags Alarming Contamination At Novo Nordisk Indiana Plant, Including Cat Hair, Bacteria, And Foreign Particles
FDA Flags Alarming Contamination At Novo Nordisk Indiana Plant, Including Cat Hair, Bacteria, And Foreign Particles
Aug 25, 2025
The U.S. Food and Drug Administration (FDA) has identified repeated quality control failures, including foreign particle contamination, inadequate investigations, and insufficient corrective actions at the Novo Nordisk A/S operated facility in Bloomington, Indiana. In 2024, Novo Nordisk ( NVO ) acquired three fill-finish sites from Novo Holdings A/S for $11 billion. The acquisition was part of a larger deal where...
Copyright 2023-2026 - www.financetom.com All Rights Reserved